CardioComm Solutions, Inc.
EKGGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.13 | 0.00 | 0.00 | -199.86 |
| FCF Yield | -5.37% | -46.65% | 2.17% | -2.18% |
| EV / EBITDA | -18.58 | -11.73 | 45.71 | 102.06 |
| Quality | ||||
| ROIC | -4,950.04% | 753.78% | -9.96% | -1,020.61% |
| Gross Margin | 96.42% | 85.43% | 74.35% | 93.40% |
| Cash Conversion Ratio | 0.57 | 0.56 | -22.21 | -426.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -19.13% | 8.69% | 6.06% | -7.94% |
| Free Cash Flow Growth | -106.21% | -226.54% | 135.91% | -627.41% |
| Safety | ||||
| Net Debt / EBITDA | -1.71 | -9.01 | 5.66 | 5.62 |
| Interest Coverage | -6.89 | -4.04 | 0.25 | -4.78 |
| Efficiency | ||||
| Inventory Turnover | 0.69 | 3.04 | 6.29 | 0.89 |
| Cash Conversion Cycle | -51.48 | -208.47 | -61.17 | -729.49 |